YCBD

Cbdmd Inc

0.9396

+0.0953+11.29%

Opening15:39 04/22 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.8152/0.8443

TODAY RANGE0.7275-1.190

VOL20.26M

MARKET CAP9.86M

52 WEEK RANGE0.4701-2.560

AVG VOL (3M)908.67K

% TURNOVER193.04%

TURNOVER--

P/E (TTM)-0.4218

% RANGE54.78%

EPS(TTM)-2.2274

P/E(FORWARD)-6.7114

P/B1.050

BVPS0.8945

DIVIDEND--

P/S0.4366

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP8.82M

SHARES OUTSTANDING10.50M

NEXT EARNINGS05/13-05/18

FREE FLOAT9.38M

LOT SIZE1

EX-DATE05/07/2025

News

Press Releases

Financial Reports

Profile

TipRanks·6d ago
cbdMD Updates Director Equity Awards and Compensation Structure
TipRanks·04/01 20:38
cbdMD Shareholders Approve Reverse Split and Capital Plans
PR Newswire·04/01 12:30
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
TipRanks·02/19 17:45
Buy Rating Reaffirmed on cbdMD: Strengthening Fundamentals, Strategic Bluebird Acquisition, and Discounted Valuation Support $2.00 Target
TipRanks·02/19 00:05
Cbdmd Inc. Earnings Call Signals Cautious Recovery
Dow Jones·02/17 21:10
Press Release: cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
Dow Jones·02/17 21:10
Press Release: cbdMD Reports Sequential Revenue -2-
PR Newswire·02/17 21:10
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
Seeking Alpha·02/17 15:00
Here are the major earnings after the close Tuesday
Seeking Alpha·02/15 22:35
cbdMD Q1 Earnings Preview
PR Newswire·02/12 22:31
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
PR Newswire·02/02 14:00
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
Dow Jones·01/29 17:55
*CbdMD Launching Integrated GRAS and Regulatory Science Program
Dow Jones·01/29 17:53
Press Release: cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
Seeking Alpha·01/14 14:10
cbdMD acquires Bluebird Botanicals in all-equity asset deal

Same Industry

Name/Symbol

Change%

Price

YCBD

McKesson

MCK

-0.11%

866.38

BIIB

Amgen Inc

AMGN

-1.04%

351.60

Shire

SHPG

0.00%

179.20

CELG-RT

Lilly Eli & Co

LLY

+2.55%

927.03

Celgene

CELG

0.00%

108.24

Therapeuticsmd Inc

TXMD

-0.48%

2.070

Johnson & Johnson

JNJ

-2.35%

225.28

Abbvie Inc

ABBV

-0.29%

208.38

Zoetis Inc

ZTS

+2.81%

122.38

Gilead Sciences Inc

GILD

-0.66%

137.64

Novo-Nordisk A/S

NVO

-1.00%

40.52

BMY

ALXN

Pfizer

PFE

+1.25%

27.56

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

NVS

Dr Reddys Labs

RDY

-1.58%

13.09

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.